Last update 08 May 2025

Sequitur, Inc.

Dissolved
| Private Company|2004|California, United States|
www.sequitur-sf.com

Overview

Related

1
Drugs associated with Sequitur, Inc.
RNA interference-based therapeutics(Intradigm/Sequitur)
Target-
Mechanism
RNA interference
Active Org.-
Originator Org.
Sequitur, Inc.
 [+1]
Active Indication-
Inactive Indication
Neoplasms
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Sequitur, Inc.
Login to view more data
0 Patents (Medical) associated with Sequitur, Inc.
Login to view more data
9
Literatures (Medical) associated with Sequitur, Inc.
01 Jan 2004Expert Review of Molecular Diagnostics
Expediting target identification and validation through RNAi
01 Aug 2003IDrugs : the investigational drugs journal
Beyond Genome 2003--RNA Interference. Silencing genes for tools and applications. 16-17 June 2003, San Diego, CA, USA.
01 Jul 2003Nature Biotechnology
Why RNAi makes sense
100 Deals associated with Sequitur, Inc.
Login to view more data
100 Translational Medicine associated with Sequitur, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
RNA interference-based therapeutics(Intradigm/Sequitur)
Neoplasms
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free